Ikarian Capital, LLC
- SEC CIK
- 0001778253
- Latest filing
- Aug 14, 2026
Holdings in Q2 2025
Holdings as of Jun 30, 2025, filed Aug 14, 2025. Long positions only; changes compare share counts with Q1 2025.
- Positions
- 103
- −13 vs. Q1 2025
- Portfolio value
- $302.2M
- −$4.71M (−1.5%) vs. Q1 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CDTXCidara Therapeutics, Inc. | COM NEW | 464,488 | $22.6M | 7.5% | +215,548+86.6% | Added | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 56,594 | $18.5M | 6.1% | +25,000+79.1% | Added | History |
| INSMINSMED Inc | COM PAR $.01 | 163,751 | $16.5M | 5.5% | +78,951+93.1% | Added | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 146,831 | $13.9M | 4.6% | +16,831+12.9% | Added | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 433,431 | $12.5M | 4.1% | −90,000−17.2% | Reduced | History |
| AKROAkero Therapeutics, Inc. | COM | 220,000 | $11.7M | 3.9% | −25,000−10.2% | Reduced | History |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 276,950 | $11.6M | 3.9% | +131,448+90.3% | Added | History |
| APGEApogee Therapeutics, Inc. | COM | 232,047 | $10.1M | 3.3% | +232,047 | New | History |
| PCVXVaxcyte, Inc. | COM | 305,000 | $9.92M | 3.3% | +105,000+52.5% | Added | History |
| ACOGAlpha Cognition Inc. | COM NEW | 917,867 | $8.56M | 2.8% | −50,000−5.2% | Reduced | History |
| TARSTarsus Pharmaceuticals, Inc. | COM | 196,536 | $7.96M | 2.6% | −288,485−59.5% | Reduced | History |
| CYTKCytokinetics Inc | COM NEW | 233,464 | $7.71M | 2.6% | +83,482+55.7% | Added | History |
| SRPTSarepta Therapeutics, Inc. | COM | 449,087 | $7.68M | 2.5% | +280,000+165.6% | Added | History |
| TGTXTG Therapeutics, Inc. | COM | 209,938 | $7.56M | 2.5% | −127−0.1% | Reduced | History |
| COGTCogent Biosciences, Inc. | COM | 1,035,528 | $7.44M | 2.5% | +1,035,528 | New | History |
| VRDNViridian Therapeutics, Inc. | COM | 469,949 | $6.57M | 2.2% | −25,000−5.1% | Reduced | History |
| ARVNArvinas, Inc. | COM | 850,000 | $6.26M | 2.1% | +620,100+269.7% | Added | History |
| FBRXForte Biosciences, Inc. | COM NEW | 476,443 | $6.16M | 2.0% | −132,782−21.8% | Reduced | History |
| VIRVir Biotechnology, Inc. | COM | 1,068,062 | $5.38M | 1.8% | 00.0% | Unchanged | History |
| CPRXCatalyst Pharmaceuticals, Inc. | COM | 209,649 | $4.55M | 1.5% | −40,000−16.0% | Reduced | History |
| DCTHDelcath Systems, Inc. | COM NEW | 322,390 | $4.38M | 1.5% | +222,025+221.2% | Added | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 40,000 | $4.24M | 1.4% | +40,000 | New | History |
| CGONCG Oncology, Inc. | COM | 155,000 | $4.03M | 1.3% | +155,000 | New | History |
| STIMNeuronetics, Inc. | COM | 1,099,700 | $3.84M | 1.3% | −3000.0% | Reduced | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 183,085 | $3.80M | 1.3% | −81,000−30.7% | Reduced | History |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 206,800 | $3.75M | 1.2% | +206,800 | New | History |
| DYNDyne Therapeutics, Inc. | COM | 363,837 | $3.46M | 1.1% | +5,000+1.4% | Added | History |
| TECXTectonic Therapeutic, Inc. | COM | 163,696 | $3.25M | 1.1% | −105,394−39.2% | Reduced | History |
| MAZEMaze Therapeutics, Inc. | COM | 262,740 | $3.22M | 1.1% | −60,000−18.6% | Reduced | History |
| JANXJanux Therapeutics, Inc. | COM | 129,691 | $3.00M | 1.0% | 00.0% | Unchanged | History |
| FULCFulcrum Therapeutics, Inc. | COM | 428,521 | $2.95M | 1.0% | +228,425+114.2% | Added | History |
| ELDNEledon Pharmaceuticals, Inc. | COM | 1,000,221 | $2.71M | 0.9% | −25,000−2.4% | Reduced | History |
| BIIBBiogen Inc. | COM | 21,516 | $2.70M | 0.9% | +21,516 | New | History |
| VKTXViking Therapeutics, Inc. | COM | 100,000 | $2.65M | 0.9% | +50,000+100.0% | Added | History |
| RLAYRelay Therapeutics, Inc. | COM | 743,308 | $2.57M | 0.9% | 00.0% | Unchanged | History |
| ARCTArcturus Therapeutics Holdings Inc. | COM | 175,000 | $2.28M | 0.8% | 00.0% | Unchanged | History |
| GERNGeron Corp | COM | 1,600,000 | $2.26M | 0.7% | +1,450,000+966.7% | Added | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 198,528 | $2.24M | 0.7% | +198,528 | New | History |
| KODKodiak Sciences Inc. | COM | 599,534 | $2.24M | 0.7% | −50,000−7.7% | Reduced | History |
| LXEOLexeo Therapeutics, Inc. | COM | 550,029 | $2.21M | 0.7% | 00.0% | Unchanged | History |
| MTSRMetsera, Inc. | COM | 77,316 | $2.20M | 0.7% | −72,684−48.5% | Reduced | History |
| VTYXVentyx Biosciences, Inc. | COM | 967,590 | $2.07M | 0.7% | −250,000−20.5% | Reduced | History |
| CPIXCumberland Pharmaceuticals Inc | COM | 595,932 | $2.00M | 0.7% | −144,068−19.5% | Reduced | History |
| PRQRProQR Therapeutics N.V. | SHS EURO | 868,069 | $1.77M | 0.6% | +868,069 | New | History |
| SRRKScholar Rock Holding Corp | COM | 49,179 | $1.74M | 0.6% | −195,000−79.9% | Reduced | History |
| DRUGBright Minds Biosciences Inc. | COM NEW | 65,431 | $1.71M | 0.6% | 00.0% | Unchanged | History |
| QUREuniQure N.V. | SHS | 119,986 | $1.67M | 0.6% | +119,986 | New | History |
| SLNSilence Therapeutics plc | ADS | 873,568 | $1.40M | 0.5% | +873,568 | New | History |
| RCUSArcus Biosciences, Inc. | COM | 163,363 | $1.33M | 0.4% | 00.0% | Unchanged | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 75,000 | $1.30M | 0.4% | 00.0% | Unchanged | History |
| ALECAlector, Inc. | COM | 900,000 | $1.26M | 0.4% | −50,000−5.3% | Reduced | History |
| NUVBNuvation Bio Inc. | COM CL A | 619,258 | $1.21M | 0.4% | 00.0% | Unchanged | History |
| VTGNVistagen Therapeutics, Inc. | COM | 601,703 | $1.20M | 0.4% | 00.0% | Unchanged | History |
| HELPHelus Pharma Inc. | COM NEW | 140,475 | $1.18M | 0.4% | −256,700−64.6% | Reduced | History |
| TRMLTourmaline Bio, Inc. | COM | 67,927 | $1.09M | 0.4% | 00.0% | Unchanged | History |
| WVEWave Life Sciences, Inc. | SHS | 161,137 | $1.05M | 0.3% | +161,137 | New | History |
| VERUVeru Inc. | COM | 1,425,239 | $829.2K | 0.3% | 00.0% | Unchanged | History |
| ORKAOruka Therapeutics, Inc. | COM | 68,574 | $768.7K | 0.3% | −106,426−60.8% | Reduced | History |
| iShares Tr464287556 | ISHARES BIOTECH | 5,755 | $728.1K | 0.2% | +5,755 | New | – |
| SGMOQSangamo Therapeutics, Inc | COM | 1,260,179 | $682.1K | 0.2% | −600,000−32.3% | Reduced | History |
| IMUXImmunic, Inc. | COM | 914,170 | $637.6K | 0.2% | 00.0% | Unchanged | History |
| INBXInhibrx Biosciences, Inc. | COM | 42,122 | $601.1K | 0.2% | 00.0% | Unchanged | History |
| IFRXInflaRx N.V. | COM | 705,010 | $557.0K | 0.2% | +705,010 | New | History |
| KZRKezar Life Sciences, Inc. | COM | 106,901 | $489.6K | 0.2% | 00.0% | Unchanged | History |
| YARWYarrow Bioscience, Inc. | COM | 290,000 | $478.5K | 0.2% | +290,000 | New | History |
| IBIOiBio, Inc. | COM NEW | 599,913 | $457.8K | 0.2% | 00.0% | Unchanged | History |
| DFTXDefinium Therapeutics, Inc. | Stock | 62,691 | $406.9K | 0.1% | 00.0% | Unchanged | History |
| HLSQTessera Defense & Homeland Security Inc. | COM NEW | 892,976 | $401.8K | 0.1% | 00.0% | Unchanged | History |
| LYELLyell Immunopharma, Inc. | COM NEW | 43,799 | $387.2K | 0.1% | 00.0% | UnchangedConverted for a 1-for-20 split | History |
| NYXHNyxoah SA | COMMONSTOCK | 50,627 | $378.7K | 0.1% | +50,627 | New | History |
| ANABAnaptysbio, Inc | COM | 15,662 | $347.7K | 0.1% | +15,662 | New | History |
| VERAVera Therapeutics, Inc. | CL A | 14,096 | $332.1K | 0.1% | +14,096 | New | History |
| ZYMEZymeworks Inc. | COM | 25,000 | $313.8K | 0.1% | +25,000 | New | History |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 265,769 | $308.3K | 0.1% | 00.0% | Unchanged | History |
| IMTXImmatics N.V. | SHS | 49,396 | $265.8K | 0.1% | +49,396 | New | History |
| VIGLVigil Neuroscience, Inc. | COM | 31,360 | $249.3K | 0.1% | −218,640−87.5% | Reduced | History |
| CMMBChemomab Therapeutics Ltd. | SPONSORED ADS | 213,052 | $247.1K | 0.1% | 00.0% | Unchanged | History |
| ANROAlto Neuroscience, Inc. | COM SHS | 110,000 | $242.0K | 0.1% | −65,000−37.1% | Reduced | History |
| RNACCartesian Therapeutics, Inc. | COM NEW | 22,166 | $230.3K | 0.1% | 00.0% | Unchanged | History |
| ANEBAnebulo Pharmaceuticals, Inc. | COM | 157,720 | $227.1K | 0.1% | 00.0% | Unchanged | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 58,491 | $218.2K | 0.1% | −250,000−81.0% | Reduced | History |
| EVAXEvaxion A/S | ADR | 80,000 | $196.0K | 0.1% | 00.0% | Unchanged | History |
| FTHFaeth Therapeutics, Inc. | COM NEW | 22,497 | $193.0K | 0.1% | 00.0% | UnchangedConverted for a 1-for-20 split | History |
| LYRALyra Therapeutics, Inc. | COM NEW | 21,161 | $189.6K | 0.1% | 00.0% | UnchangedConverted for a 1-for-50 split | History |
| AEMDAethlon Medical Inc | COM NEW | 153,659 | $184.4K | 0.1% | 00.0% | UnchangedConverted for a 1-for-8 split | History |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 35,300 | $176.1K | 0.1% | −164,700−82.4% | Reduced | History |
| VYGRVoyager Therapeutics, Inc. | COM | 55,766 | $173.4K | 0.1% | 00.0% | Unchanged | History |
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 176,479 | $166.9K | 0.1% | −1,241,473−87.6% | Reduced | History |
| PEPGPepGen Inc. | COM | 150,000 | $166.5K | 0.1% | 00.0% | Unchanged | History |
| JSPRJasper Therapeutics, Inc. | COM NEW | 25,107 | $139.3K | <0.1% | 00.0% | Unchanged | History |
| KPTIKaryopharm Therapeutics Inc. | COM NEW | 27,257 | $117.5K | <0.1% | 00.0% | Unchanged | History |
| MGNXMacrogenics Inc | COM | 80,071 | $96.9K | <0.1% | 00.0% | Unchanged | History |
| SGMTSagimet Biosciences Inc. | COM SER A | 11,984 | $91.3K | <0.1% | 00.0% | Unchanged | History |
| AIRSAirsculpt Technologies, Inc. | COM | 17,951 | $86.7K | <0.1% | +17,951 | New | History |
| SPRBSpruce Biosciences, Inc. | COM | 1,000,000 | $72.5K | <0.1% | 00.0% | Unchanged | History |
| TKNOAlpha Teknova, Inc. | COM | 14,008 | $68.8K | <0.1% | 00.0% | Unchanged | History |
| HOOKHOOKIPA Pharma Inc. | COM | 52,996 | $66.5K | <0.1% | 00.0% | Unchanged | History |
| TOVXTheriva Biologics, Inc. | COM NEW | 120,031 | $52.1K | <0.1% | 00.0% | Unchanged | History |
| TRAWTraws Pharma, Inc. | COM NEW | 28,493 | $42.2K | <0.1% | 00.0% | Unchanged | History |
| AMIXAutonomix Medical, Inc. | COM NEW | 20,000 | $31.4K | <0.1% | 00.0% | Unchanged | History |
Options (24)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| CDTXCidara Therapeutics, Inc. | COM NEW | $24.4M | $15.6M |
| SLNOSoleno Therapeutics Inc | COM | $16.8M | $16.8M |
| RAREUltragenyx Pharmaceutical Inc. | COM | $10.9M | $20.5M |
| CAPRCapricor Therapeutics, Inc. | COM NEW | $13.5M | $6.95M |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | $9.18M | $4.46M |
| Uniqure NVN90064901 | CALL | – | $11.2M |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | – | $10.2M |
| VKTXViking Therapeutics, Inc. | COM | – | $9.28M |
| SRPTSarepta Therapeutics, Inc. | COM | – | $5.68M |
| CYTKCytokinetics Inc | COM NEW | – | $4.96M |
| KALVKalVista Pharmaceuticals, Inc. | COM | – | $4.52M |
| Biohaven LtdG1110E907 | CALL | – | $4.23M |
| APGEApogee Therapeutics, Inc. | COM | $3.44M | $364.8K |
| FULCFulcrum Therapeutics, Inc. | COM | – | $3.67M |
| VERAVera Therapeutics, Inc. | CL A | – | $3.61M |
| SRRKScholar Rock Holding Corp | COM | – | $3.54M |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | – | $3.35M |
| ALTAltimmune, Inc. | COM NEW | – | $3.20M |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | – | $2.63M |
| AKROAkero Therapeutics, Inc. | COM | – | $2.37M |
| COGTCogent Biosciences, Inc. | COM | – | $1.89M |
| PRTAProthena Corp Public Ltd Co | SHS | – | $607.0K |
| KYMRKymera Therapeutics, Inc. | COM | $436.4K | – |
| PCVXVaxcyte, Inc. | COM | – | $224.3K |
Sold out since Q1 2025 (33)
Positions held at the end of Q1 2025 that are gone from this filing.
| Security | Class | Shares in Q1 2025 | Value in Q1 2025 | % of portfolio in Q1 2025 | History |
|---|---|---|---|---|---|
| SPYSPDR S&P 500 ETF Trust | ETF | 25,000 | $14.0M | 4.6% | History |
| BPMCBlueprint Medicines Corp | COM | 113,904 | $10.1M | 3.3% | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 216,989 | $7.86M | 2.6% | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 280,000 | $6.16M | 2.0% | History |
| ELVNEnliven Therapeutics, Inc. | COM | 289,538 | $5.70M | 1.9% | History |
| TRVITrevi Therapeutics, Inc. | COM | 575,000 | $3.62M | 1.2% | History |
| BBIOBridgeBio Pharma, Inc. | COM | 90,837 | $3.14M | 1.0% | History |
| KROSKeros Therapeutics, Inc. | COM | 274,009 | $2.79M | 0.9% | History |
| ABEOAbeona Therapeutics Inc. | COM NEW | 533,581 | $2.54M | 0.8% | History |
| EOLSEvolus, Inc. | COM | 193,265 | $2.32M | 0.8% | History |
| VERVVerve Therapeutics, Inc. | COM | 358,393 | $1.64M | 0.5% | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 221,911 | $1.48M | 0.5% | History |
| TDOCTeladoc Health, Inc. | COM | 150,000 | $1.19M | 0.4% | History |
| OKUROnKure Therapeutics, Inc. | COM CL A | 253,754 | $1.09M | 0.4% | History |
| NKTRNektar Therapeutics | COM | 1,579,528 | $1.07M | 0.3% | History |
| SLDBSolid Biosciences Inc. | COM NEW | 230,000 | $851.0K | 0.3% | History |
| ETNB89bio, Inc. | COM | 100,000 | $727.0K | 0.2% | History |
| OLMAOlema Pharmaceuticals, Inc. | COM | 191,994 | $721.9K | 0.2% | History |
| GLUEMonte Rosa Therapeutics, Inc. | COM | 136,575 | $633.7K | 0.2% | History |
| PTHSPelthos Therapeutics Inc. | Equity | 440,849 | $626.0K | 0.2% | History |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 613,253 | $600.9K | 0.2% | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 12,519 | $552.5K | 0.2% | History |
| ITOSiTeos Therapeutics, Inc. | COM | 78,585 | $469.2K | 0.2% | History |
| THRDThird Harmonic Bio, Inc. | COM | 100,000 | $347.0K | 0.1% | History |
| DNAGinkgo Bioworks Holdings, Inc. | CL A NEW | 58,300 | $332.3K | 0.1% | History |
| TYRATyra Biosciences, Inc. | COM | 35,000 | $325.5K | 0.1% | History |
| ALLKAllakos Inc. | COM | 1,171,950 | $266.7K | 0.1% | History |
| ACRSAclaris Therapeutics, Inc. | COM | 150,900 | $230.9K | 0.1% | History |
| MNPRMonopar Therapeutics | COM NEW | 5,908 | $215.1K | 0.1% | History |
| CLYMClimb Bio, Inc. | COM | 175,088 | $213.6K | 0.1% | History |
| ELEVElevation Acquisition Group Inc. | COM | 690,050 | $178.8K | 0.1% | History |
| RZLTRezolute, Inc. | COM NEW | 50,058 | $145.2K | <0.1% | History |
| LRMRLarimar Therapeutics, Inc. | COM | 58,526 | $125.8K | <0.1% | History |